Focal segmental glomerulosclerosis historical perspective: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
{{CMG}}, {{APM}}; {{AE}} {{MKK}}, {{OO}} | {{CMG}}, {{APM}}; {{AE}} {{MKA}}, {{MKK}}, {{OO}} | ||
==Overview== | ==Overview== | ||
Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German [[pathologist]], in 1925, and he referred to it as "[[lipoid nephrosis]] with [[degeneration]]", showing a clear association to [[minimal change disease]]. In 1957, FSGS was then described by Dr. Arnold Rich, a [[pathologist]] at [[Johns Hopkins University School of Medicine|Johns Hopkins University]]. | Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German [[pathologist]], in 1925, and he referred to it as "[[lipoid nephrosis]] with [[degeneration]]", showing a clear association to [[minimal change disease]]. In 1957, FSGS was then described by Dr. Arnold Rich, a [[pathologist]] at [[Johns Hopkins University School of Medicine|Johns Hopkins University]]. | ||
Line 20: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] |
Latest revision as of 21:46, 29 July 2020
Focal segmental glomerulosclerosis Microchapters |
Differentiating Focal segmental glomerulosclerosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Focal segmental glomerulosclerosis historical perspective On the Web |
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis historical perspective |
FDA on Focal segmental glomerulosclerosis historical perspective |
CDC on Focal segmental glomerulosclerosis historical perspective |
Focal segmental glomerulosclerosis historical perspective in the news |
Blogs on Focal segmental glomerulosclerosis historical perspective |
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
Risk calculators and risk factors for Focal segmental glomerulosclerosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [3], Manpreet Kaur, MD [4], Olufunmilola Olubukola M.D.[5]
Overview
Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German pathologist, in 1925, and he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.
Historical Perspective
Discovery
- Focal segmental glomerulosclerosis (FSGS) was first discovered by Theodor Fahr, a German pathologist, in 1925.[1]
- He referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease.[2]
- In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.[3]
- In 1970, Jacob Churg and colleagues finally classified FSGS as a unique renal glomerulopathy in the " Pathology of the Nephrotic Syndrome in Children: Report for the International Study of Kidney Disease in Children" in view of its clinical and pathological features, and its steroid-resistance in comparison to minimal change disease.[4]
References
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ RICH AR (1957). "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis". Bull Johns Hopkins Hosp. 100 (4): 173–86. PMID 13426687.
- ↑ Churg J, Habib R, White RH (1970). "Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children". Lancet. 760 (1): 1299–302. PMID 4193942.